We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

RGA:NYSEReinsurance Group of America, Incorporated Analysis

Data as of 2026-05-24 - not real-time

$214.04

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

RGA is trading in a bullish technical environment, with the short‑term moving average comfortably above the longer‑term average and the MACD line sitting above its signal, signaling upward momentum. The RSI sits in a neutral zone, suggesting room for further upside without immediate overbought pressure, while volume trends are tapering, indicating a cautious but stable buying interest. Fundamentals reinforce the technical picture: earnings have accelerated across regions, the company posted a strong first‑quarter performance, and management highlighted disciplined capital deployment. The dividend payout remains modest relative to earnings, supporting sustainability and appealing income‑focused investors.
Valuation metrics point to a compelling entry point: the price‑to‑earnings multiple sits well below the industry norm, and the discounted cash‑flow model suggests a significant upside potential. Revenue growth remains robust, and cash generation comfortably covers debt obligations, further lowering financial risk. Combined, these factors make RGA an attractive candidate for investors seeking a blend of growth and defensive qualities.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish technical indicators (SMA crossover, MACD bullish)
  • Strong quarterly earnings beat
  • Modest dividend payout supporting cash flow

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Revenue growth outpacing peers
  • Undervalued valuation relative to earnings and industry
  • Sustainable dividend with low payout ratio

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Diversified global reinsurance platform
  • Consistent free cash flow generation
  • Low beta and defensive sector positioning

Key Metrics & Analysis

Financial Health

Revenue Growth23.50%
Profit Margin4.92%
P/E Ratio11.6
ROE9.90%
ROA0.85%
Debt/Equity45.61
P/B Ratio1.1
Op. Cash Flow$5.5B
Free Cash Flow$4.8B
Industry P/E16.8

Technical Analysis

TrendBullish
RSI55.4
Support$204.28
Resistance$221.90
MA 20$211.39
MA 50$207.90
MA 200$199.98
MACDBullish
VolumeDecreasing
Fear & Greed Index91.61

Valuation

Fair Value$2,461.45
Target Price$250.56
Upside/Downside17.06%
GradeUndervalued
TypeGrowth
Dividend Yield1.74%

Risk Assessment

Beta0.68
Volatility17.45%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.